Millennium Management’s Nuvectis Pharma NVCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $233K | Sell |
31,167
-89,934
| -74% | -$672K | ﹤0.01% | 3655 |
|
|
2025
Q1 | $1.18M | Buy |
121,101
+91,403
| +308% | +$893K | ﹤0.01% | 2894 |
|
|
2024
Q4 | $161K | Sell |
29,698
-38,801
| -57% | -$210K | ﹤0.01% | 3718 |
|
|
2024
Q3 | $431K | Sell |
68,499
-50,960
| -43% | -$321K | ﹤0.01% | 3378 |
|
|
2024
Q2 | $756K | Buy |
119,459
+79,958
| +202% | +$506K | ﹤0.01% | 3018 |
|
|
2024
Q1 | $324K | Buy |
39,501
+5,490
| +16% | +$45K | ﹤0.01% | 3474 |
|
|
2023
Q4 | $284K | Buy |
+34,011
| New | +$284K | ﹤0.01% | 3419 |
|
|
2023
Q2 | – | Sell |
-24,667
| Closed | -$323K | – | 4580 |
|
|
2023
Q1 | $323K | Buy |
+24,667
| New | +$323K | ﹤0.01% | 3625 |
|
|
2022
Q2 | – | Sell |
-42,160
| Closed | -$312K | – | 5414 |
|
|
2022
Q1 | $312K | Buy |
+42,160
| New | +$312K | ﹤0.01% | 4387 |
|